510(k) device
SDS Growing Rod
BAAT Medical Products B.V. · Growing Rod System (PGM, Class II) · First FDA decision Jan 15, 2026, newest Jan 15, 2026Scoliosis and spinal deformity
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
16
Naming "SDS"
MAUDE reports
192
Brand "SDS", since 2015
PubMed studies
92,148
Mentioning "SDS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing SDS Growing Rod
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- SDS Growing RodBreakthrough510(k)
K251961 · Decided Jan 15, 2026 · 203 days after receipt
Device type: Growing Rod System (PGM) · Orthopedic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "SDS", any status and sponsor, newest update first.
- Synchronized Diaphragmatic Stimulation in Symptomatic Heart FailurePivotal-lookingRecruiting
VisCardia Inc.Not on our public-company list
NCT06552637 · 270 participants (planned) · Start Jul 8, 2026 · Primary completion Jul 2028
Device: Synchronized Diaphragmatic Stimulation · For: Heart Failure With Reduced Ejection Fraction
Sites: Indianapolis, Indiana; Tulsa, Oklahoma; Philadelphia, Pennsylvania · 7 sites in all
Acurable Ltd.Not on our public-company list
NCT04031950 · 345 participants (planned) · Start Feb 19, 2020 · Primary completion Oct 14, 2027
Device: Novel wearable paediatric device · For: Sleep Apnea
Sites: Sheffield, United Kingdom; Southampton, United Kingdom
G. d'Annunzio UniversityAcademic, hospital or other
NCT07568353 · 40 participants (planned) · Start Dec 1, 2026 · Primary completion May 31, 2027
Device: Perceptive Surface (SU-PER mat) · For: Low Back Pain; Healthy
Sites: Chieti, Italy
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "SDS", and for the whole product code for context.
This brand
192 reports: 156 malfunction, 32 injury, 4 death
Whole product code PGM
40 reports: 18 malfunction, 21 injury, 1 death
Newest reports for this brand
- CARDIO SDS/STENTMalfunction
9616099-2025-01081 · Received Jul 9, 2025 · Event dated Jun 12, 2025
Device type: Catheter, Angioplasty, Peripheral, Transluminal (LIT)
Device problem as coded: Burst Container or Vessel
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- SDS AMIIA GENESIS 6.0X18 142Malfunction
9616099-2023-06321 · Received Mar 10, 2023 · Event dated Feb 14, 2023
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE)
Device problem as coded: Material Protrusion/Extrusion
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
9616099-2023-06209 · Received Jan 9, 2023 · Event dated Dec 14, 2022
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE)
Device problem as coded: Device Dislodged or Dislocated
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "SDS"[tiab]. The summary above synthesizes these.
- One-dimensional SDS-polyacrylamide gel electrophoresis (1D SDS-PAGE).
Brunelle JL, Green R · Methods Enzymol · 2014Research Support, Non-U.S. Gov't
- SDS Polyacrylamide Gel Electrophoresis of Proteins.
Smith BJ · Methods Mol Biol · 1984
- SDS protein interactions.
Arakawa T, Ejima D, Ura T, et al. · Biophys Chem · 2026Review
- Predisposition to myeloid malignancies in Shwachman-Diamond syndrome: biological insights and clinical advances.
Reilly CR, Shimamura A · Blood · 2023Review, Research Support, N.I.H., Extramural
- SDS-PAGE and Western Blotting.
Al-Tubuly AA · Methods Mol Med · 2000
- Analysis of Peroxisome Biogenesis by Phos-Tag SDS-PAGE.
Okumoto K, Fujiki Y · Methods Mol Biol · 2023Research Support, Non-U.S. Gov't
- Silver staining of SDS-polyacrylamide gel.
Kavran JM, Leahy DJ · Methods Enzymol · 2014
- Low-SDS Blue native PAGE.
Klodmann J, Lewejohann D, Braun HP · Proteomics · 2011Research Support, Non-U.S. Gov't
- Diversity of cortical activity changes beyond depression during Spreading Depolarizations.
Nasretdinov A, Vinokurova D, Lemale CL, et al. · Nat Commun · 2023Research Support, Non-U.S. Gov't
- SDS induces amorphous, amyloid-fibril, and alpha-helical structures in the myoglobin in a concentration-dependent manner.
AlResaini S, Malik A, Alonazi M, et al. · Int J Biol Macromol · 2023
- SDS modulates amyloid fibril formation and conformational change in succinyl-ConA at low pH.
Khan JM, Malik A, Ahmed MZ, et al. · Spectrochim Acta A Mol Biomol Spectrosc · 2022
- The battle of the sexes in humans is highly polygenic.
Cole JM, Scott CB, Johnson MM, et al. · Proc Natl Acad Sci U S A · 2024Research Support, N.I.H., Extramural
Other devices of this type
Also filed under product code PGM.
- VerteGlide Spinal Growth Guidance SystemOrthoPediatrics Corp. · 510(k) 2025
- MARVEL Growing RodsGlobus Medical, Inc. · 510(k) 2022
- Daytona® Small Stature Growth Rod Conversion SetSeaSpine Orthopedics Corporation · 510(k) 2020
- CrossOver Cross ConnectorsMedos International SARL · 510(k) 2019
- CREO® Stabilization System, REVERE® Stabilization SystemGlobus Medical, Inc. · 510(k) 2018
- Polaris Spinal Growth SystemZimmer Biomet Spine, Inc. · 510(k) 2018
- NuVasive® Growth Rod Conversion SetNu Vasive, Incorporated · 510(k) 2017
- K2M Growing Spine SystemK2m, Inc. · 510(k) 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.